A recent pre-print showed that scientists in China can earn up to $165,000 to publish a paper in a top journal, but that’s not the only place where researchers can get some extra cash. Recently, we conducted an informal search for other institutions around the world that offer cash prizes for publishing research — and … Continue reading Paid to publish: It’s not just China
A trove of internal documents from Monsanto, recently unsealed in a lawsuit against the agricultural biotech giant, has revealed the firm’s role in the knotty tale of a paper from the lab of a scientist known for his stance against genetically modified organisms (GMOs). That paper is “Long term toxicity of a Roundup herbicide and … Continue reading Unearthed emails: Monsanto connected to campaign to retract GMO paper
Three years after an investigation revealed a 2013 paper was based on fraudulent data, a journal has finally retracted it. The paper, published in Journal of Hazardous Materials, was one of seven articles by a team at the Institute of Microbial Technology (IMTECH) in Chandigarh, India that contain fabricated data, according to an investigation by … Continue reading The three-year delay: Journal finally retracts paper based on made-up data
Four hundred eighty-six authors have been found guilty of misconduct by the Chinese government, the fall-out from a sweep of retractions by one journal earlier this year. In April, Tumor Biology retracted 107 papers that had been accepted based on faked reviews. Since many of the authors were based in China, the country’s Ministry of Science … Continue reading Nearly 500 researchers guilty of misconduct, says Chinese gov’t investigation
The week at Retraction Watch featured authors making a difficult decision to retract once-promising findings about gliobastoma, and sanctions for a researcher in whose lab image manipulations were found. Here’s what was happening elsewhere:
WASHINGTON, D.C — Last week, former brain scientist Christian Kreipke stared down the third set of research misconduct allegations against him since 2011. Or, possibly, according to him, it was the third iteration of the same research misconduct allegations he’s faced for years, a piling on by the most powerful of the three institutions out … Continue reading Ex-Wayne State scientist, ORI square off in court
Longtime readers of Retraction Watch may recall a 2011 post about a research team that retracted a paper after realizing that they had ordered the wrong mice. Maureen Gannon and Raymond Pasek of Vanderbilt University contacted us earlier this week to alert us to a similar case: Their retraction, earlier this month, of a 2016 paper … Continue reading “We were devastated:” Authors retract paper after realizing they had used the wrong mice
The week at Retraction Watch featured a story of unintended consequences and a broken relationship, and a retraction for a paper that had just about everything wrong with it. Here’s what was happening elsewhere:
Suing the government is difficult. And because public universities often function as an arm of state governments, that makes them hard to sue, too, a fact reiterated in a whistleblower case decided earlier this year. In January, Judge David Hale of the Western District of Kentucky dismissed a lawsuit filed by former employees of the … Continue reading Failed whistleblower suit is a reminder that public universities are hard to sue
The week at Retraction Watch featured the tale of a scientist whose explanations for misconduct kept changing, and revelations in a big legal case involving Duke University. Here’s what was happening elsewhere: